Market News AIOpen the app

An analyst is feeling positive about Editas Medicine and shares four company upgrades for Wednesday.

OpinionRead the original at benzinga.com
Good for MSFT

Stifel upgraded Microsoft to Buy and raised the price target to $575; that raises analyst support for Microsoft.

MSFT · Microsoft Corp

AI read · Good for MSFT

The AI's read

Stifel's upgrade and a higher $575 price target raise Wall Street support for Microsoft and imply higher analyst expectations. The $575 target sits well above the $498 close, strengthening the bullish read despite a tiny intraday price dip.

GPK · Graphic Packaging Holding Co

AI read · Neutral

The connection

JP Morgan upgraded Graphic Packaging to Overweight but also cut the price target from $12.5 to $11.5, leaving the two facts to cancel each other.

EDIT · Editas Medicine Inc

AI read · Good for EDIT

The connection

Guggenheim upgraded Editas Medicine to Buy and set a $5 price target, which increases analyst support relative to the $2.92 close.

LKFT · Lakefront Biotherapeutics NV – ADR

AI read · Good for LKFT

The connection

RBC raised Lakefront Biotherapeutics to Outperform and lifted the price target to $45, which raises analyst optimism for the company.

Get alerts for MSFT

Follow Microsoft Corp (MSFT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MSFT
Free on the App Store and Google Play, or on the web.